Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast CancerStephen Chan, John Crown, Simon Van Belle et al.|Journal of Clinical Oncology|1999Cited by 639
HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent DocetaxelAngelo Di Leo, Denis Larsimont, Stephen Chan et al.|Breast Cancer Research and Treatment|2004Cited by 138